← FDA Drug Approvals (Drugs@FDA)
RYSTIGGO
BLA · Biologics License Application · Sponsor: UCB INC · Approved 2023-06-26
Drug application
- FDA Application #
BLA761286- Application type
- Biologics License Application
- Brand name
- RYSTIGGO
- Generic name
- ROZANOLIXIZUMAB
- Active ingredients
- ROZANOLIXIZUMAB-NOLI
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- UCB INC
- Manufacturer
- UCB, Inc.
- First approval
- 2023-06-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown